PHARMACOECONOMIC GUIDELINES RECOMMENDATION FOR TURKEY CONSIDERING REFERENCE COUNTRIES

被引：0

作者：

Mihajlovic, J. ^{[1
]}

Yegenoglu, S. ^{[2
]}

Sahne, Sozen B. ^{[2
]}

Postma, M. ^{[3
]}

机构：

[1] Univ Groningen, Groningen, Netherlands

[2] Hacettepe Univ, Ankara, Turkey

[3] Univ Groningen, Groningen, Netherlands

来源：

VALUE IN HEALTH | 2018年 / 21卷

关键词：

D O I：

10.1016/j.jval.2018.09.1153

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

PHP259

引用

页码：S194 / S194

页数：1

共 50 条

[41] Recommendation System "Virtual Reference"
Rzheuskyi, Antonii
Kunanets, Nataliia
Stakhiv, Mykola
[J]. 2018 IEEE 13TH INTERNATIONAL SCIENTIFIC AND TECHNICAL CONFERENCE ON COMPUTER SCIENCES AND INFORMATION TECHNOLOGIES (CSIT), VOL 2, 2018, : 203 - 206
[42] IMPACT OF PHARMACOECONOMIC GUIDELINES ON THE REIMBURSEMENT PROCESS OF MEDICINES IN SERBIA IN 2014
Baltezarevic, D.
Novakovic, T.
Parker, M.
Samardzic, J.
[J]. VALUE IN HEALTH, 2014, 17 (07) : A407 - A407
[43] Pharmacoeconomic Guidelines and Their Implementation in the Positive List System in South Korea
Bae, Eun Young
Lee, Eui Kyung
[J]. VALUE IN HEALTH, 2009, 12 : S36 - S41
[44] Countries and Peoples of Turkey
Oberhummer, E.
[J]. PETERMANNS MITTEILUNGEN, 1921, 67 : 203 - 203
[45] The South African Guidelines for Pharmacoeconomic Submissions' Evidence Requirements Compared with Other African Countries and The National Institute for Health and Care Excellence in England
Marsh, Sophia E.
Truter, Ilse
[J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2020, 20 (02) : 155 - 168
[46] Publication of pharmacoeconomic data submitted to reimbursement or clinical guidelines agencies
Mauskopf, J
Drummond, M
[J]. VALUE IN HEALTH, 2004, 7 (05) : 515 - 516
[47] DEVELOPMENT OF PHARMACOECONOMIC GUIDELINES IN UKRAINE: METHODOLOGICAL ISSUES AND POLICY IMPLICATIONS
Piniazhko, O.
Zalis'ka, O.
Nemeth, B.
[J]. VALUE IN HEALTH, 2017, 20 (09) : A699 - A699
[48] Recommendations on HRQL/utility data in 14 European pharmacoeconomic guidelines
Szende, A
Rentz, A
Kline, LN
[J]. VALUE IN HEALTH, 2002, 5 (06) : 460 - 460
[49] Data Generalizability, Data Transferability, and the Political Economy of Pharmacoeconomic Guidelines
Turk, Florian
[J]. VALUE IN HEALTH, 2010, 13 (08) : 863 - 864
[50] How to improve pharmacoeconomic data generalisability between different countries
Li, Shu Chuen
[J]. EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (10) : 1409 - 1413

← 1 2 3 4 5 →